Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SELECT trial of perioperative selective digestive decontamination in elective colorectal cancer surgery
NL-OMON44116Phase 3Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- May 2013
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of selective digestive decontamination in colorectal cancer (CRC) (2 arms), sponsored by Vrije University Medical Center. Primary endpoint: Anastomotic leakage. Started May 2013; status: active, not recruiting.
02
Drugs
selective digestive decontamination
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON44116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44116.